Episode 076: Management of primary refractory diffuse large B-cell lymphoma (DLBCL)

The Fellow on Call: The Heme/Onc Podcast

Content provided by Ronak Mistry and Rouleaux University Medical Center. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ronak Mistry and Rouleaux University Medical Center or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

9M ago

MP3•Episode home

This week, we pick up on our discussion about management of DLBCL, focusing on the primary refractory setting. A big part of this discussion is the role of CAR-T therapy. If you have not done so already, we highly recommend you check out episode 075 for the fundamentals of CAR-T before proceeding with this episode!

Content:

- Definitions for "primary refractory" vs. "relapsed" disease

- How do we approach patients with primary refractory disease?

- What are the treatment regimens for patients with primary refractory disease?

- What is the role of CAR-T therapy?

- How do we "bridge" patients to CAR-T therapy?

- How do we monitor patients post CAR-T?

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast

114 episodes

#Ronak Mistry #Rouleaux University Medical Center #Science #Fitness #Biology #Podcasting Education #Medicine #Lung Cancer